Technologies Available for Licensing
ANTIVIRAL RIFT VALLEY FEVER VIRUS PEPTIDES AND METHODS OF USE
The invention entails synthetic short peptides based on Rift Valley Fever Virus (RVFV) fusion protein. The peptides are broad-spectrum antivirals, and are useful for prophylactic treatment against or therapeutic treatment of infection by hemorrhagic fever viruses, such as RVFV, Ebola Virus, and Andes Virus, as well as vesicular stomatitis virus.
More Detail:Visit USPTO.GOV